DPP-4 Inhibitor-Related Pancreatitis: Rare but Real!

Affiliations

¹ Department of Endocrinology, Academic Medical Center at the University of Amsterdam, Amsterdam, the Netherlands j.h.devries@amc.uva.nl.
² Dallas Diabetes Research Center, Dallas, TX.

Comment

J Hans DeVries et al. Diabetes Care. 2017 Feb.

. 2017 Feb;40(2):161-163.

doi: 10.2337/dci16-0035.

¹ Department of Endocrinology, Academic Medical Center at the University of Amsterdam, Amsterdam, the Netherlands j.h.devries@amc.uva.nl.
² Dallas Diabetes Research Center, Dallas, TX.

No abstract available

Comment on

Pancreatic Safety of Sitagliptin in the TECOS Study.
Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group. Buse JB, et al. Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14. Diabetes Care. 2017. PMID: 27630212 Free PMC article. Clinical Trial.
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes.
Tkáč I, Raz I. Tkáč I, et al. Diabetes Care. 2017 Feb;40(2):284-286. doi: 10.2337/dc15-1707. Epub 2016 Sep 22. Diabetes Care. 2017. PMID: 27659407 Review.